SunLink Health Systems, Inc.

As of September 28, 2022, SunLink Health Systems, Inc. is considered overvalued and risky due to poor financial metrics and long-term performance, despite a strong short-term stock return of 26.7%.

As of June 11, 2025, the trend is mildly bullish due to positive weekly MACD and daily moving averages, but caution is advised because of a bearish monthly RSI and mixed signals from other indicators.

As of September 28, 2022, SunLink Health Systems, Inc. is considered overvalued and risky, with key financial ratios indicating distress, especially when compared to peers like Brookdale Senior Living and National HealthCare Corp., despite a strong one-year return of 63.69%.

As of March 2022, the management team of SunLink Health Systems, Inc. includes Mr. Robert Thornton as Chairman, President, and CEO, along with independent directors Dr. Steven Baileys, Mr. Gene Burleson, Mr. C. Ford, Mr. Christopher Mills, and Mr. Howard Turner.

SunLink Health Systems, Inc. operates in the healthcare sector, providing services through its subsidiaries in the hospital industry. As of March 2025, it reported net sales of $7 million and a net profit loss of $1 million, with a market cap of $7.01 million.

As of Jun 18, SunLink Health Systems, Inc. has a market capitalization of 7.01 million, with net sales of 31.08 million and a net profit of -2.79 million for the latest four quarters ending in Mar'25. The company reported shareholder's funds of 15.97 million and total assets of 20.61 million as of Jun'24.